ArticleJuntendo Iji zasshi = Juntendo medical journal2024
The Up-to-date Treatment for Diabetes and Prevention of its Complications.
Article in Juntendo Iji zasshi = Juntendo medical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- GLP-1 receptor agonists in stroke prevention: a narrative review on emerging therapeutic frontiers.Annals of medicine · 2026Review
- Calebin A mitigates oxidative stress and inflammation in diabetic nephropathy via Nrf2/HO-1 and NF-κB signaling pathways.Journal of diabetes investigation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetes mellitus, characterized by high blood glucose due to inadequate insulin action, comprises two main types: type 1, an autoimmune disease, and type 2, marked by insulin resistance. This review provides a comprehensive overview of diabetes management and treatment advancements. Effective diabetes management includes maintaining blood glucose levels within normal ranges and monitoring HbA1c, a marker reflecting average glucose levels over the past few months. Historically, the discovery of insulin in 1921 revolutionized diabetes treatment, significantly extending patient life expectancy. Current treatment strategies encompass diet, exercise, and pharmacotherapy. The diet involves a balanced intake of carbohydrates, proteins, and fats, while exercise, including aerobic and resistance training, improves insulin sensitivity and glucose control. Pharmacotherapy options include insulin therapy and oral hypoglycemic agents, like metformin and empagliflozin, each with specific mechanisms of action. Innovative treatments include SGLT2 inhibitors and GLP-1 receptor agonists, which aid in glucose control and offer additional benefits like weight loss and improved cardiovascular outcomes. Continuous glucose monitoring (CGM) and insulin pumps represent technological advancements enhancing glycemic control through real-time monitoring and automated insulin delivery. We must pay attention to diabetes-related stigma, which we should overcome by advocacy. The diabetes education programs at Juntendo University Hospital aim to improve patient self-management through comprehensive diet, exercise, and medication education. We emphasize the importance of integrating the latest research and societal support to enable diabetic patients to lead healthy, fulfilling lives.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.